Aura Biosciences, Inc. SEC filings AURA
Aura Biosciences, Inc. has 381 filings in SEC EDGAR's recent list, going back to Sep 21, 2010. Its latest annual report, Form ARS, was filed on Apr 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations, exit or restructuring costs, officer or director change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Officer or director change, Other events
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 8, 2026 | Jul 3, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
May 11, 2026 | May 11, 2026 |
| 8-K |
Current report
Material agreement
|
May 5, 2026 | May 4, 2026 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
May 4, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
May 4, 2026 | Apr 29, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 30, 2026 | Mar 30, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 13, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
May 16, 2025 | May 15, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change
|
May 15, 2025 | May 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 2, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 24, 2025 | Mar 24, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 17, 2024 | Oct 17, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 27, 2024 | Sep 23, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 12, 2024 | Sep 12, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 21, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Other events
|
Jun 4, 2024 | Jun 4, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 15, 2024 | Apr 12, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2024 | Mar 27, 2024 |
| 8-K |
Current report
Other events
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Material agreement, Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 6, 2023 | Nov 6, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 2, 2023 | Sep 26, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 9, 2023 | Aug 9, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2023 | Jun 7, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 4, 2023 | Apr 3, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 15, 2023 | Mar 15, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 16, 2023 | Feb 16, 2023 |
| 8-K |
Current report
Other events
|
Jan 6, 2023 | Jan 6, 2023 |
| 8-K |
Current report
Material agreement
|
Dec 5, 2022 | Nov 30, 2022 |
| 8-K |
Current report
Other events
|
Nov 30, 2022 | Nov 30, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 3, 2022 | Oct 2, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 28, 2022 | Sep 28, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 30, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 22, 2022 | Jun 19, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2022 | Jun 15, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
May 27, 2022 | May 26, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
May 18, 2022 | May 16, 2022 |
| 8-K |
Current report
Results of operations
|
May 12, 2022 | May 12, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2022 | Mar 23, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 24, 2021 | Nov 24, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Nov 2, 2021 | Nov 2, 2021 |
Showing 52 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- AURA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1501796
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.